Consolidated Financial Results by Business Segment
Net Sales
(Unit: Millions of yen)
| | Medical-Related | Pharmaceutical-Related | PharmaPackaging | Other | Total |
|---|
| '21/3 |
343,824 |
72,388 |
38,655 |
691 |
455,559 |
| '22/3 |
373,481 |
74,386 |
46,361 |
559 |
494,789 |
Operating Income
(Unit: Millions of yen)
| | Medical-Related | Pharmaceutical-Related | PharmaPackaging | Other | Adjustment | Total |
|---|
| '21/3 |
38,879 |
10,608 |
1,992 |
376 |
-24,229 |
27,627 |
| '22/3 |
39,241 |
9,826 |
2,889 |
101 |
-28,175 |
23,882 |
Net Sales by Region
(Unit: Millions of yen)
| | Japan | America | Europe | Asia | Total |
|---|
| Net sales | Proportion |
Net sales | Proportion |
Net sales | Proportion |
Net sales | Proportion |
Net sales |
| '19/3 |
260,967 |
61.2% |
59,836 |
14.0% |
51,042 |
12.0% |
54,552 |
12.8% |
426,399 |
| '20/3 |
267,708 |
60.5% |
64,153 |
14.5% |
50,801 |
11.5% |
59,853 |
13.5% |
442,516 |
| '21/3 |
270,543 |
59.40% |
71,572 |
15.70% |
52,167 |
11.50% |
61,275 |
13.50% |
455,559 |
| '22/3 |
280,094 |
56.61% |
78,242 |
15.81% |
60,376 |
12.20% |
76,075 |
15.38% |
494,789 |
Proportion of Net Sales by Region (2022/3)
